Corporate Events

Sep 9, 2013 15th Annual Rodman & Renshaw Conference Sept. 9, 2013

15th Annual Rodman & Renshaw Global Investment Conference, New York City - Sept. 9, 2013

http://wsw.com/webcast/rrshq23/ATOS

Aug 26, 2013 Atossa Rings Nasdaq Closing Bell - 3:45 pm ET

Atossa Genetics rings the Closing Bell at Nasdaq on Aug. 26, 2013. Live webcast.

http://www.nasdaq.com/about/marketsitetowervideo.asx

Aug 14, 2013 2Q13 Earnings Conference Call; 4:45 pm ET

2Q13 Earnings Conference Call: A webcast will be available on the Company's website at http://client.irwebkit.com/AtossaGenetics/#irkit

http://services.choruscall.com/links/atossa130725.html

Jul 10, 2013 Atossa Genetics to present at The Life Science Innovation Northwest 2013 Conference on Wednesday, July 10, 2013, at 10:45 am Pacific Time at the Washington State Convention Center.

The Life Science Innovation Northwest 2013 Conference presentation will take place on Wednesday, July 10, 2013, at 10:45 am Pacific Time at the Washington State Convention Center.

http://m360.washbio.org/event.aspx?eventID=73301

Jul 9, 2013 Atossa Genetics to Present at The JMP Securities Healthcare Conference on Tuesday, July 9, 2013, at 2:00 pm Eastern Time at the St. Regis Hotel, NY, NY

The JMP Securities Healthcare Conference presentation will take place on Tuesday, July 9, 2013, at 2:00 pm Eastern Time at the St. Regis Hotel.

http://www.jmpg.com/jmpsecurities/about/conferences

Jun 7, 2013 Atossa Genetics to present at the Sidoti & Co., Micro-Cap Conference at the Grand Hyatt Hotel, 109 E 42nd Street New York, NY

Atossa Genetics will present the Company’s business model, growth strategy and products and services at the Sidoti & Co., Micro-Cap Conference at the Grand Hyatt Hotel, 109 E 42nd Street New York, NY

http://microcap.sidoti.com/

May 30, 2013 Atossa Genetics to present at the Marcum MicroCap Conference, at the Grand Hyatt Hotel, 109 E 42nd Street, NY, NY

Atossa Genetics will present the Company’s business model, growth strategy and products and services at the Marcum MicroCap Conference, at the Grand Hyatt Hotel, 109 E 42nd Street, NY, NY

http://www.marcumllp.com/MicroCap/presenting-companies

May 22, 2013 Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and President of Atossa Genetics, will participate in a panel discussion on Diagnostics at the Sachs Cancer Bio Partnering Forum at the Westin Copley Place, Boston, MA

Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and President of Atossa Genetics, will participate in a panel discussion on Diagnostics at the Sachs Cancer Bio Partnering Forum, at the Westin Copley Place, Boston, MA

http://www.sachsforum.com/boston13/

May 22, 2013 Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and President of Atossa Genetics, will present at the Sachs Cancer Bio Partnering Forum, at the Westin Copley Place, Boston, MA at 11:00am in the Essex North Room

Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO and President of Atossa Genetics, will present at the Sachs Cancer Bio Partnering Forum, at the Westin Copley Place, Boston, MA at 11:00am in the Essex North Room

http://www.sachsforum.com/boston13/

May 4, 2013 Atossa Genetics to Exhibit at 61st Annual Clinical Meeting of the American Congress of Obstetrics and Gynecology in New Orleans, LA, from May 4 - 8, 2013, in booth #728 at the Ernest N. Morial Convention Center.

Atossa Genetics to Exhibit at American Congress of Obstetrics and Gynecology Meeting
Atossa Genetics will display its ForeCYTE Breast Health Test at the 61st Annual Clinical Meeting of the American Congress of Obstetrics and Gynecology in New Orleans from May 4 - 8, 2013. The Atossa exhibit will be located in booth #728 at the Ernest N. Morial Convention Center.

http://www.acog.org/acm/

Mar 19, 2013 25th Annual ROTH Conference

Steven C. Quay, M.D., Ph.D., FCAP, Chairman, CEO & President and Kyle Guse, CFO and general counsel will present the Company’s business model, growth strategy and products and services at the 25th Annual ROTH Conference at the Ritz-Carlton Laguna Niguel in Dana Point, California, on Tuesday, March 19, 2013, at 3:30 pm Pacific Time (6:30 pm Eastern Time). The presentation will be broadcast at the link below:

http://wsw.com/webcast/roth27/register.aspx?conf=roth27&page=atos&url=http%3A//wsw.com/webcast/roth27/atos/

Jan 28, 2013 Personalized Medicine World Congress 2013 Speaking Engagement: Dr. Steven Quay presents The "Care Path" Business Model in Personalized Medicine

Track II 9:45am

Steven C Quay, M.D., Ph.D., FCAP, Founder, Atossa Genetics, Inc.

The "Care Path" Business Model in Personalized Medicine

As medical practice moves toward more ‘protocol’ driven treatment paradigms, the ability of genomics-based diagnostic companies to launch innovative tests becomes ever more difficult. Using the CarePath business model and the understanding of practice patterns to design products and services to address the entire CarePath of a disease or condition provides an innovative way to distinguish a start-up company from the crowd, establish synergies across all parts of the business, and build stakeholder value for the organization. The Breast Health CarePath established by Atossa Genetics, comprising five FDA-cleared medical devices, four CLIA-validated Laboratory Developed Tests, and a pharmaceutical/ biotech treatment program, will be provided as an example.

http://2013sv.pmwcintl.com/program.php

Jan 28, 2013 Personalized Medicine World Conference 2013 Speaking Engagement: Dr. Steven Quay presents Breast Cancer Prevention Through Diagnosis and Treatment

Track I 4:15pm

Breast Cancer Prevention Through Diagnosis and Treatment

Speaker: Steven C Quay, M.D., Ph.D., FCAP, Founder, Atossa Genetics, Inc.

How to obtain routine, repeated, painless breast biopsy samples non-invasively for cytopathology, NGS, proteome, and transcriptome analysis of precursors to breast cancer; Identifying the earliest “-omic” changes in reversible precursor lesions of the breast, such as atypical ductal hyperplasia; The use of breast specimens obtained non-invasively for biomarker discovery, clinical trial support, and patient selection, and to inform personalized medical therapy; Cancer prevention using intraductal treatment of reversible hyperplastic lesions

http://2013sv.pmwcintl.com/program.php

Dec 6, 2012 Atossa to present at the 2nd Annual Cancer Genome Summit in Boston MA

The Cancer Genome Summit is the only meeting that brings together thought leaders from pharma, academia and the clinic, to discuss how they are harnessing the cancer genome to revolutionize their drug development programs and patient treatment choices, including the latest clinical data. Sharing these insights holds the key to accessing the cancer genome. This year’s meeting will show attendees how to identify new drug targets, combat resistance mechanisms, streamline clinical trials and improve clinical management.

http://cancergenome-summit.com

Dec 5, 2012 Atossa to present at the 5th Annual LD Micro Conference at the Luxe Sunset Bel Air Hotel in Los Angeles, CA

The LD Micro Conference is a two-day conference organized by LD Micro, a by-invitation only newsletter firm that focuses on undervalued companies in the micro-cap space.

http://www.ldmicro.com.

IR Events

Jun 4, 2014 Sysorex will present the company's business model and growth strategy at the 4th annual Ld Micro Conference at 10:00am on 6/4/14 at the Luxe Hotel Los Angeles, CA

Sysorex will present the company's business model and growth strategy at the 4th annual Ld Micro Conference at 10:00am on 6/4/14 at the Luxe Hotel Los Angeles, CA

http://www.ldmicro.com

Jun 4, 2014 Sysorex will present the company's business model and growth strategy at the 4th annual Ld Micro Conference at 10:00am on 6/4/14 at the Luxe Hotel Los Angeles, CA

Sysorex will present the company's business model and growth strategy at the 4th annual Ld Micro Conference at 10:00am on 6/4/14 at the Luxe Hotel Los Angeles, CA

http://www.ldmicro.com

Jun 4, 2014 Sysorex will present the company's business model and growth strategy at the 4th annual Ld Micro Conference at 10:00am on 6/4/14 at the Luxe Hotel Los Angeles, CA

Sysorex will present the company's business model and growth strategy at the 4th annual Ld Micro Conference at 10:00am on 6/4/14 at the Luxe Hotel Los Angeles, CA

http://www.ldmicro.com

Apr 25, 2013 Kyle Guse to present at 2:40pm at the San Francisco, CA FSX Conference

Kyly Guse to present at the San Francisco, CA FSX Conference on April 25, 2013

http://www.fsxinterlinked.com/fsx-conferences/fsx-san-fran-april-25-2013/

Feb 11, 2013 2013 BIO CEO Conference, Webcast link: http://www.veracast.com/webcasts/bio/ceoinvestor2013/87115258.cfm

The Waldorf Astoria, New York, NY
February 11 - 12, 2013
Powell, Track D

http://www.bio.org/events/conferences/bio-ceo-investor-conference

Feb 7, 2013 FSX Conference, Dallas, TX, February 7, 2013

Financial Services Exchange Conference, Dallas, TX

http://www.fsxinterlinked.com/fsx-conferences/fsx-dallas-february-7-9-2013/

Jan 22, 2013 Atossa Genetics, Inc. to Present at NINE 2013 - Noble Financial Capital Markets' Ninth Annual Equity Conference, Hard Rock Hotel & Casino, Hollywood, Florida, 3:00pm, Room 3, Live Webcast at the following link: http://noble.mediasite.com/mediasite/Play/2ebeafa21e284567aa7f0448eb05a4291d

Atossa Genetics, Inc. to Present at NINE 2013 - Noble Financial Capital Markets' Ninth Annual Equity Conference, Hard Rock Hotel & Casino, Hollywood, Florida, 3:00pm, Room 3, Live Webcast at the following link http://noble.mediasite.com/mediasite/Play/2ebeafa21e284567aa7f0448eb05a4291d

http://www.nobleresearch.com/a/index.php

Jan 9, 2013 Biotech Showcase 2013

10:00Am Pacific time
Parc 55 Wyndham San Francisco - Union Square

http://www.ebdgroup.com/bts/index.php

Jan 8, 2013 6th Annual OneMedForum SF2013 Live presentation webcast at http://www.onemedplace.com/forum/webcast/#page=page-a

January 8, 2013, 4:00 PM Pacific Time
Sir Francis Drake Hotel, San Francisco
Live presentation webcast at http://www.onemedplace.com/forum/webcast/#page=page-a

http://www.onemedplace.com/forum/

Dec 5, 2012 Live Audio Webcast with Slides of Atossa Genetics' Inc Presentation at LD Micro Conference

Dr. Steven C. Quay, M.D., Ph.D., FCAP, chairman, CEO and President of Atossa Genetics, Inc., will discuss the Company's novel approaches to breast cancer risk assessment and prevention, 2013 growth initiatives and unique investment proposition.

After clicking on the webcast link below, you will be directed to the proper conference's registration page. After completing the required fields and clicking "Register," you will then brought to your dedicated webcast page.

The presentation will be archived for 90 days.

http://wsw.com/webcast/ldmicro3/atos/

IR website by IR WebKit